Your prediction
Takeda Pharmaceutical Co Ltd Stock
Takeda Pharmaceutical Co Ltd took a tumble today and lost -€1.090 (-3.470%).
Our community identified positive and negative aspects for Takeda Pharmaceutical Co Ltd stock for the coming years. 1 users see the criterium "Business model" as a plus for the Takeda Pharmaceutical Co Ltd stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Takeda Pharmaceutical Co Ltd in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Takeda Pharmaceutical Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | -3.470% | -0.807% | -2.415% | 9.366% | 17.483% | 0.821% | -7.164% |
| Eisai Co Ltd | 1.690% | 1.872% | -6.547% | -3.223% | 2.431% | -48.944% | -55.729% |
| Chugai Pharmaceutical Co Ltd | 0.750% | -8.973% | -14.940% | 11.844% | 3.222% | 97.282% | 29.777% |
| Astellas Pharma Inc. | 0.580% | -0.692% | -6.137% | 39.398% | 12.931% | -0.768% | -9.043% |
Comments
News
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
